Generalized Pustular Psoriasis Prevalence Rises 56% Over 15 Years
GPP prevalence climbed 56% over 15 years, Medscape reports, signaling a shift for a rare neutrophilic dermatosis long considered ultra-rare in dermatology.
Topic
Gpp
Topic
Gpp
FDA Accepts BLA for Imsidolimab in Generalized Pustular Psoriasis
FDA accepts for review a BLA for imsidolimab, an IL-36–targeting monoclonal antibody, as a treatment for generalized pustular pso…